North America Long Read Sequencing Market Size & Outlook
The long read sequencing market in North America is expected to reach a projected revenue of US$ 1,466.6 million by 2033. A compound annual growth rate of 21.66% is expected of North America long read sequencing market from 2026 to 2033.
North America long read sequencing market highlights
The North America long read sequencing market generated a revenue of USD 316.2 million in 2025.
The market is expected to grow at a CAGR of 21.66% from 2026 to 2033.
In terms of segment, sequencing was the largest revenue generating workflow in 2025.
Data Analysis is the most lucrative workflow segment registering the fastest growth during the forecast period.
Country-wise, Canada is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
Market revenue in 2025
USD 316.2 million
Market revenue in 2033
USD 1,466.6 million
Growth rate
21.66% (CAGR from 2026 to 2033)
Largest segment
Sequencing
Fastest growing segment
Data Analysis
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Data Analysis, Pre-sequencing, Sequencing
Key market players worldwide
Pacific Biosciences of California Inc, Oxford Nanopore Technologies PLC, Eurofins Scientific SE, Roche Holding AG ADR, New England Biolabs, Huawei Technologies, BGI Group, Quantapore, Element Biosciences, MicrobesNG
Other key industry trends
In terms of revenue, North America region accounted for 51.7% of the global long read sequencing market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 759.0 million by 2033.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Long Read Sequencing Market Outlook will help companies and investors design strategic landscapes.
Sequencing was the largest segment with a revenue share of 73.37% in 2025.
Horizon Databook has segmented the North America long read sequencing market based on data analysis, pre-sequencing, sequencing covering the revenue growth of each sub-segment from 2021 to 2033.
North America Long Read Sequencing Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Pre-sequencing
Data Analysis
Sequencing
North America Long Read Sequencing Market Product Outlook (Revenue, USD Million , 2021-2033)
Instruments
Consumables
Services
North America Long Read Sequencing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Others
North America Long Read Sequencing Market Technology Outlook (Revenue, USD Million , 2021-2033)
Nanopore Sequencing
Single Molecule Real Time Sequencing
Others
North America Long Read Sequencing Market Application Outlook (Revenue, USD Million , 2021-2033)
Whole Genome Sequencing
Targeted Sequencing
Metagenomics
Others
RNA Sequencing
Epigenetics
Reasons to subscribe to Long Read Sequencing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Long Read Sequencing Market Outlook databook
Our clientele includes a mix of Long Read Sequencing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Long Read Sequencing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Long Read Sequencing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Long Read Sequencing Market, 2021-2033 (US$M)